Geoff Allan

Posted on 21/04/2023

Geoff joined Rayner in April 2023 with over 35 years of international finance and legal experience and has worked in venture capital, investment banking and in operational roles, notably in the technology and healthcare sectors.
Most recently, Geoff was CFO of the Paris based global healthcare company, HRA Pharma, where he spent over 11 years and was responsible for finance, tax, legal affairs, and procurement. Geoff was closely involved in the sale of the business to two leading private equity firms – Astorg and Goldman Sachs – in 2016.  Under their ownership, HRA completed several acquisitions, notably those of the blister market leader Compeed and of the leading US scar care brand Mederma and saw revenues grow eight times. Geoff was highly involved in the negotiations for sale of HRA to the US listed consumer healthcare company, Perrigo, for $2.1 billion in 2022.
Geoff holds law degrees from King’s College, University of London and from the Sorbonne in Paris. He is a keen skier and enjoys spending time with his family, getting to the gym, and watching rugby.
Share this article